Cerebrospinal Fluid Drainage Catheter

Cerebrospinal Fluid Drainage Catheter Market Outlook

The global Cerebrospinal Fluid Drainage Catheter market is projected to reach approximately USD 1.5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 5.8% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing incidence of neurological disorders such as hydrocephalus, traumatic brain injuries, and other conditions requiring cerebrospinal fluid management. Furthermore, advancements in medical technology, coupled with the rising geriatric population, are expected to significantly boost the demand for cerebrospinal fluid drainage catheters. The expansion of healthcare infrastructure, particularly in developing regions, along with the rising awareness of preventive healthcare, is also positively influencing market dynamics. Additionally, the ongoing research and development efforts aimed at improving catheter designs and materials will likely contribute to market growth.

Growth Factor of the Market

The cerebrospinal fluid drainage catheter market is witnessing substantial growth due to several key factors. The rising prevalence of neurological conditions, particularly in aging populations, necessitates the use of effective drainage methods to manage cerebrospinal fluid. Advances in catheter technology, such as the development of safer and more effective materials, are also driving market expansion. Furthermore, the increasing number of surgical procedures involving intracranial pressures, especially in emergency care settings, is propelling the demand for these devices. Hospitals and healthcare facilities are increasingly recognizing the importance of effective cerebrospinal fluid management, leading to enhanced investments in medical equipment. Finally, the expansion of healthcare services in emerging economies further bolsters the demand for cerebrospinal fluid drainage catheters.

Key Highlights of the Market

• The cerebrospinal fluid drainage catheter market is expected to grow significantly due to the rising prevalence of neurological disorders.
• Technological advancements in catheter design and materials are enhancing patient safety and comfort.
• Hospitals remain the primary distribution channel, accounting for the largest share of the market.
• North America is expected to dominate the market in terms of revenue, driven by advanced healthcare infrastructure.
• Emerging markets in Asia Pacific and Latin America present significant growth opportunities due to increasing healthcare investments.

By Product Type

Ventricular Catheters:

Ventricular catheters are a pivotal segment within the cerebrospinal fluid drainage catheter market. These catheters are specifically designed for insertion into the ventricles of the brain, allowing for the effective management of cerebrospinal fluid in conditions such as hydrocephalus. The increasing prevalence of hydrocephalus, particularly among pediatric populations, is driving the demand for ventricular catheters. In addition, advancements in catheter technology, including the development of programmable valves that can regulate flow rates, are enhancing the utility of these devices in clinical settings. The emphasis on minimally invasive procedures is also contributing to the growing preference for ventricular catheters among neurosurgeons and healthcare providers.

Lumbar Catheters:

Lumbar catheters are another crucial product type in the cerebrospinal fluid drainage catheter market, primarily utilized for draining cerebrospinal fluid from the lumbar region of the spine. These catheters are commonly employed in cases of spinal surgery and managing conditions such as subarachnoid hemorrhages. The rising incidence of lower back disorders and the increasing number of lumbar surgeries are propelling the demand for lumbar catheters. Moreover, the ease of insertion and the effectiveness of lumbar catheters in relieving symptomatic pressure make them a preferred choice among healthcare professionals. The growth in outpatient procedures and the movement towards less invasive techniques further bolster this segment's market performance.

Cisternal Catheters:

Cisternal catheters play a significant role in the cerebrospinal fluid drainage catheter market, providing access to the cisternal space for drainage purposes. These catheters are particularly useful in managing intracranial pressure resulting from various neurological conditions, including traumatic brain injury and brain tumors. The growing awareness regarding the importance of effective cerebrospinal fluid management in critical care settings is driving the demand for cisternal catheters. Moreover, their application in neurocritical care units where prompt intervention is critical for patient outcomes enhances their relevance in the market. Continuous innovations in catheter design, aimed at improving functionality and patient outcomes, further contribute to the growth of this segment.

Subdural Catheters:

Subdural catheters are increasingly recognized for their utility in draining cerebrospinal fluid from the subdural space, especially following traumatic brain injuries. These catheters are essential in managing post-operative complications and preventing the buildup of cerebrospinal fluid that can lead to increased intracranial pressure. The rising incidence of traumatic brain injuries globally is significantly impacting the demand for subdural catheters. As more healthcare facilities adopt advanced monitoring techniques, the role of subdural catheters in ensuring effective cerebrospinal fluid drainage becomes ever more critical. Moreover, their adoption in emergency medical settings further enhances their market significance, as timely intervention can substantially affect patient recovery outcomes.

Subarachnoid Catheters:

Subarachnoid catheters are utilized primarily for the management of cerebrospinal fluid in the subarachnoid space, often used in procedures involving spinal anesthesia and pain management. The increasing number of spinal surgeries and the rising prevalence of chronic pain conditions are driving the demand for subarachnoid catheters. Additionally, their efficacy in delivering medications directly into the cerebrospinal fluid for targeted therapy enhances their appeal in clinical practice. As hospitals and healthcare facilities focus on improving patient outcomes, the adoption of subarachnoid catheters is becoming increasingly common. Continuous developments in catheter materials and designs are also contributing to the growth of this segment, ensuring better patient safety and comfort.

By Application

Hydrocephalus:

The application of cerebrospinal fluid drainage catheters in managing hydrocephalus is a major factor driving market growth. Hydrocephalus, characterized by the accumulation of cerebrospinal fluid in the ventricles of the brain, requires timely intervention to prevent neurological damage. The increasing incidence of this condition, particularly in neonates and the elderly, is propelling the demand for effective drainage solutions. Ventricular catheters are typically employed for this purpose, allowing for the continuous removal of excess cerebrospinal fluid. Awareness of hydrocephalus and its management is growing, resulting in higher diagnosis rates and subsequent treatment options, which further enhances the market's potential.

Traumatic Brain Injury:

The incidence of traumatic brain injury (TBI) is a critical application driving the cerebrospinal fluid drainage catheter market. TBIs can result in increased intracranial pressure, necessitating the use of drainage catheters to manage cerebrospinal fluid effectively. With the rising prevalence of road accidents, sports-related injuries, and falls, the demand for catheters designed for TBI management is on the rise. Healthcare providers are increasingly implementing protocols for monitoring and managing intracranial pressure in trauma patients, further increasing the use of cerebrospinal fluid drainage catheters. The advanced training among medical professionals regarding the quick management of TBI outcomes also contributes to market growth.

Intracranial Hemorrhage:

The management of intracranial hemorrhage is another significant application for cerebrospinal fluid drainage catheters. Conditions such as subdural and epidural hematomas often require immediate intervention to alleviate pressure on the brain. The use of drainage catheters allows for the effective removal of pooled blood and cerebrospinal fluid, reducing the risk of long-term neurological damage. The increasing prevalence of conditions that lead to hemorrhages, such as hypertension and vascular malformations, is driving the need for these catheters. Additionally, advancements in catheter technology that offer improved safety and efficacy are propelling this application segment forward.

Brain Tumor:

Cerebrospinal fluid drainage catheters are also utilized in the management of brain tumors, particularly in cases where the tumor leads to increased intracranial pressure. The presence of a brain tumor can disrupt normal cerebrospinal fluid flow, necessitating the use of drainage catheters to maintain proper intracranial pressure levels. The rising incidence of brain tumors globally is fueling the demand for these products, as timely management can significantly impact patient outcomes. Furthermore, the integration of catheter systems with monitoring devices enhances the ability to manage cerebrospinal fluid effectively, driving further adoption in clinical settings.

Others:

In addition to the primary applications mentioned, several other conditions necessitate the use of cerebrospinal fluid drainage catheters. These include complications from neurosurgical procedures, infections, and congenital malformations. The versatility of cerebrospinal fluid drainage catheters allows them to be employed in various clinical scenarios, thus expanding their market potential. As healthcare providers continue to seek effective solutions for complex neurological conditions, the demand for these catheters will likely persist. Additionally, ongoing research into new applications and improvements in catheter technology will likely open new avenues for growth within this segment.

By Distribution Channel

Hospitals:

Hospitals remain the leading distribution channel for cerebrospinal fluid drainage catheters, accounting for a significant share of the market. The high volume of neurosurgical procedures performed in hospitals contributes to the increased demand for these catheters. Hospitals are equipped with advanced medical facilities and trained personnel who can efficiently manage complications arising from cerebrospinal fluid disorders. The emphasis on comprehensive patient care and the availability of specialized departments such as neurosurgery further enhance the adoption of cerebrospinal fluid drainage catheters within hospital settings. Additionally, hospitals are increasingly investing in advanced technologies and equipment, driving the demand for high-quality drainage solutions.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming an increasingly important distribution channel for cerebrospinal fluid drainage catheters. These centers focus on providing same-day surgical services and are often equipped to handle less complex procedures, including those requiring cerebrospinal fluid management. The shift towards outpatient care and minimally invasive procedures is driving the growth of ASCs, as patients seek shorter hospital stays and quicker recovery times. As the healthcare industry evolves to accommodate outpatient services, the adoption of cerebrospinal fluid drainage catheters in ASCs is expected to rise, contributing to the overall market growth.

Specialty Clinics:

Specialty clinics, particularly those focusing on neurology and neurosurgery, are emerging as key distribution channels for cerebrospinal fluid drainage catheters. These clinics cater to patients with specific neurological conditions, offering tailored treatment options that often involve the use of drainage catheters. The increasing establishment of specialty clinics is a response to the rising demand for specialized care and expertise in managing complex neurological disorders. Furthermore, the collaboration between specialty clinics and hospitals enhances patient access to advanced treatment options, leading to an increase in the utilization of cerebrospinal fluid drainage catheters.

Others:

Other distribution channels for cerebrospinal fluid drainage catheters include online sales platforms and medical supply distributors. The rise of e-commerce in the healthcare sector is making it easier for healthcare providers to access a range of medical supplies, including drainage catheters. Additionally, medical supply distributors play a crucial role in ensuring that healthcare facilities have access to the necessary equipment and supplies. As the market continues to evolve, the diversification of distribution channels, including online platforms, will enhance accessibility and drive the demand for cerebrospinal fluid drainage catheters.

By Material Type

Silicone:

Silicone is a prominent material used in the manufacturing of cerebrospinal fluid drainage catheters, known for its biocompatibility and flexibility. Silicone catheters allow for safe and effective drainage while minimizing the risk of irritation to surrounding tissues. The increasing demand for silicone drainage catheters can be attributed to their durability and resistance to occlusion, making them suitable for long-term use. Furthermore, advancements in silicone technology have led to the development of catheters that can withstand extreme conditions, driving their adoption in critical care settings. The preference for silicone due to its proven performance and safety profile continues to bolster its market presence.

Polyurethane:

Polyurethane catheters are also gaining traction in the cerebrospinal fluid drainage catheter market due to their excellent mechanical properties and ability to reduce the risk of infections. Polyurethane offers a balance between flexibility and strength, making it an ideal choice for various drainage applications. The material's hydrophilic properties enhance patient comfort, reducing the likelihood of complications associated with catheter insertion. Additionally, the advancements in polyurethane technology, such as antimicrobial coatings, are contributing to its growing popularity. As healthcare providers prioritize patient safety and comfort, the demand for polyurethane drainage catheters is expected to rise significantly.

Others:

Other materials used in the production of cerebrospinal fluid drainage catheters include various composites and blends designed to enhance performance attributes. These materials aim to combine the advantages of different polymers to create catheters that are both effective and comfortable for patients. Innovations in catheter design and materials are driven by ongoing research to improve functionality and reduce infection risks. As the healthcare sector continues to evolve, the exploration of alternative materials for cerebrospinal fluid drainage catheters is likely to expand, catering to the specific needs of healthcare providers and patients alike.

By Region

The regional analysis of the cerebrospinal fluid drainage catheter market reveals significant variations in market dynamics across different geographical areas. North America is expected to dominate the market, with a projected market share of approximately 45% due to the presence of advanced healthcare infrastructure, high prevalence of neurological disorders, and significant investments in medical technology. The region's robust regulatory framework and emphasis on patient safety further contribute to the market's growth. With a CAGR of 6.2% during the forecast period, North America is expected to maintain its leadership position, driven by ongoing innovations and healthcare advancements.

In contrast, the Asia Pacific region is anticipated to exhibit the highest growth rate during the forecast period, with a CAGR of 7.0%. Factors such as the rising population, increasing incidence of neurological conditions, and expanding healthcare facilities are driving demand in this region. The growing awareness of cerebrospinal fluid management and the need for advanced medical devices contribute to the market's expansion. Countries such as China and India are witnessing rapid growth in their healthcare sectors, fostering an increase in the use of cerebrospinal fluid drainage catheters. As healthcare expenditure in these regions continues to rise, the demand for effective drainage solutions is expected to follow suit.

Opportunities

One of the most significant opportunities in the cerebrospinal fluid drainage catheter market lies in the increasing focus on research and development aimed at innovating catheter designs. As the medical industry continues to evolve, there is a growing demand for devices that are not only effective but also enhance patient comfort and safety. Companies that invest in R&D to create advanced catheter systems, such as those with integrated monitoring capabilities or made from novel biocompatible materials, stand to gain a competitive edge. Furthermore, partnerships between manufacturers and healthcare providers can lead to the development of tailored solutions that meet specific medical needs, thereby expanding market opportunities.

Additionally, the increasing prevalence of neurological disorders, coupled with the growing geriatric population, presents a significant opportunity for market expansion. As the number of patients requiring cerebrospinal fluid management rises, healthcare providers will need to ensure they have access to effective drainage solutions. Manufacturers that can establish strong distribution networks and provide comprehensive training for healthcare professionals on the effective use of these devices can significantly enhance their market presence. Furthermore, emerging markets in regions like Asia Pacific and Latin America offer untapped potential for growth as healthcare infrastructure continues to improve and patient awareness increases.

Threats

Despite the promising growth prospects, the cerebrospinal fluid drainage catheter market faces several threats that could hinder its expansion. One of the primary concerns is the increasing prevalence of hospital-acquired infections associated with catheter use. Infections can lead to severe complications and can deter healthcare providers from utilizing drainage catheters, impacting market growth. Furthermore, stringent regulatory requirements related to medical devices can pose challenges for manufacturers looking to introduce new products to the market. Compliance with these regulations requires significant time and financial resources, potentially limiting innovation and product development.

Moreover, competition from alternative treatment options and therapies may impact the demand for cerebrospinal fluid drainage catheters. As advancements in neurosurgery and non-invasive treatment options emerge, healthcare providers may be inclined to adopt these alternatives, leading to reduced demand for traditional drainage catheters. Additionally, price sensitivity in certain markets can limit the willingness of healthcare providers to invest in high-quality products, further affecting market dynamics. Manufacturers will need to navigate these challenges while continuing to innovate and enhance the value proposition of their products.

Competitor Outlook

• Medtronic PLC
• B. Braun Melsungen AG
• Smiths Medical
• Codman & Shurtleff, Inc.
• Integra LifeSciences Corporation
• Johnson & Johnson
• ConvaTec Group PLC
• Terumo Corporation
• Abbott Laboratories
• Boston Scientific Corporation
• Halyard Health, Inc.
• Ethicon, Inc.
• Teleflex Incorporated
• MicroPort Scientific Corporation
• Getinge AB

The competitive landscape of the cerebrospinal fluid drainage catheter market is characterized by a mix of established and emerging players aiming to capture market share through innovative products and strategic partnerships. Major companies such as Medtronic PLC and B. Braun Melsungen AG are leveraging their extensive product portfolios and strong distribution networks to maintain their leadership positions. These companies are also heavily investing in research and development to introduce advanced catheter technologies that enhance patient safety and efficacy. The competitive rivalry in this market is further intensified by the presence of specialized manufacturers catering to niche applications, thereby driving continuous innovation and improvement in catheter design and functionality.

Another aspect of the competitive landscape is the growing trend of mergers and acquisitions among key players, aimed at expanding product offerings and enhancing market reach. For instance, strategic acquisitions allow companies to combine resources, access new markets, and leverage complementary technologies. This trend not only boosts the capabilities of the acquiring companies but also fosters innovation by integrating diverse expertise and insights. Furthermore, companies are focusing on establishing collaborations with healthcare providers to better understand market needs and develop products that address specific clinical challenges, thus creating a more patient-centric approach to product development.

Major players in the market, such as Integra LifeSciences Corporation and Codman & Shurtleff, Inc., are focusing on enhancing their market presence by expanding their product lines and exploring new geographical regions. They are also investing in marketing and promotional activities to raise awareness about their products and educate healthcare professionals on their benefits. As the market evolves, companies that can effectively differentiate their products through unique features, superior quality, and comprehensive support services will likely gain a competitive advantage. The emphasis on patient outcomes and the growing demand for high-quality medical devices will continue to shape the competitive landscape of the cerebrospinal fluid drainage catheter market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Getinge AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Ethicon, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic PLC
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smiths Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ConvaTec Group PLC
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Halyard Health, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 B. Braun Melsungen AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teleflex Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Codman & Shurtleff, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Integra LifeSciences Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 MicroPort Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Cerebrospinal Fluid Drainage Catheter Market, By Application
    • 6.1.1 Hydrocephalus
    • 6.1.2 Traumatic Brain Injury
    • 6.1.3 Intracranial Hemorrhage
    • 6.1.4 Brain Tumor
    • 6.1.5 Others
  • 6.2 Cerebrospinal Fluid Drainage Catheter Market, By Product Type
    • 6.2.1 Ventricular Catheters
    • 6.2.2 Lumbar Catheters
    • 6.2.3 Cisternal Catheters
    • 6.2.4 Subdural Catheters
    • 6.2.5 Subarachnoid Catheters
  • 6.3 Cerebrospinal Fluid Drainage Catheter Market, By Material Type
    • 6.3.1 Silicone
    • 6.3.2 Polyurethane
    • 6.3.3 Others
  • 6.4 Cerebrospinal Fluid Drainage Catheter Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Cerebrospinal Fluid Drainage Catheter Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Cerebrospinal Fluid Drainage Catheter market is categorized based on

By Product Type

• Ventricular Catheters
• Lumbar Catheters
• Cisternal Catheters
• Subdural Catheters
• Subarachnoid Catheters

By Application

• Hydrocephalus
• Traumatic Brain Injury
• Intracranial Hemorrhage
• Brain Tumor
• Others

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Material Type

• Silicone
• Polyurethane
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic PLC
• B. Braun Melsungen AG
• Smiths Medical
• Codman & Shurtleff, Inc.
• Integra LifeSciences Corporation
• Johnson & Johnson
• ConvaTec Group PLC
• Terumo Corporation
• Abbott Laboratories
• Boston Scientific Corporation
• Halyard Health, Inc.
• Ethicon, Inc.
• Teleflex Incorporated
• MicroPort Scientific Corporation
• Getinge AB